tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IMMP Stock Latest News

Immutep Reports Increased Losses Amid Rising R&D Costs
Company AnnouncementsImmutep Reports Increased Losses Amid Rising R&D Costs
1d ago
6K
IMMP
Immutep Gains FDA Support for Eftilagimod Alfa in Cancer Treatment
PremiumCompany Announcements
Immutep Gains FDA Support for Eftilagimod Alfa in Cancer Treatment
28d ago
6K
IMMP
Immutep’s Strategic Advances and Promising Clinical Data Drive Buy Rating
PremiumRatings
Immutep’s Strategic Advances and Promising Clinical Data Drive Buy Rating
29d ago
IMMP
Immutep receives FDA feedback on clinical development of eftilagimod alfa
PremiumThe Fly
Immutep receives FDA feedback on clinical development of eftilagimod alfa
1M ago
IMMP
Immutep Reports Significant Progress in Cancer and Autoimmune Trials
PremiumCompany Announcements
Immutep Reports Significant Progress in Cancer and Autoimmune Trials
1M ago
6K
IMMP
Immutep reports Q4 cash receipts from customers A$6,000
PremiumThe FlyImmutep reports Q4 cash receipts from customers A$6,000
1M ago
IMMP
Immutep Reports Promising Phase I Results for IMP761 in Autoimmune Diseases
Premium
Company Announcements
Immutep Reports Promising Phase I Results for IMP761 in Autoimmune Diseases
2M ago
6K
IMMP
Immutep announces initial efficacy data from Phase I study of IMP761
Premium
The Fly
Immutep announces initial efficacy data from Phase I study of IMP761
2M ago
IMMP
Immutep’s Efti Combination Therapy Shows Promising Results in Soft Tissue Sarcoma Trial
PremiumCompany Announcements
Immutep’s Efti Combination Therapy Shows Promising Results in Soft Tissue Sarcoma Trial
3M ago
6K
IMMP
Immutep announces EFTISARC-NEO Phase II trial met primary endpoint
PremiumThe Fly
Immutep announces EFTISARC-NEO Phase II trial met primary endpoint
3M ago
IMMP
Immutep’s Promising Phase 1 INSIGHT-003 Results Drive Buy Rating
PremiumRatings
Immutep’s Promising Phase 1 INSIGHT-003 Results Drive Buy Rating
4M ago
IMMP
Immutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
PremiumCompany Announcements
Immutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
4M ago
6K
IMMP
Immutep announces response rates from INSIGHT-003 trial
PremiumThe FlyImmutep announces response rates from INSIGHT-003 trial
4M ago
IMMP
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
MRK
ATHE
Immutep’s Promising Phase 2b Results and Strong Financial Position Justify Buy Rating
Premium
Ratings
Immutep’s Promising Phase 2b Results and Strong Financial Position Justify Buy Rating
4M ago
IMMP
Immutep’s Efti Shows Promising Results in Head and Neck Cancer Trial
PremiumCompany Announcements
Immutep’s Efti Shows Promising Results in Head and Neck Cancer Trial
4M ago
6K
IMMP
Immutep announces results from Phase IIb trial of TACTI-003
PremiumThe Fly
Immutep announces results from Phase IIb trial of TACTI-003
4M ago
MRK
IMMP
Immutep Achieves Key Milestones in Cancer Trials with Strong Financial Backing
PremiumCompany Announcements
Immutep Achieves Key Milestones in Cancer Trials with Strong Financial Backing
4M ago
6K
IMMP
Immutep reports Q3 cash receipts from customers A$12,000
PremiumThe Fly
Immutep reports Q3 cash receipts from customers A$12,000
4M ago
IMMP
Immutep’s Promising Clinical Developments and Strategic Collaborations Earn a Buy Rating
PremiumRatingsImmutep’s Promising Clinical Developments and Strategic Collaborations Earn a Buy Rating
5M ago
IMMP
Immutep announces first patient dosed in TACTI-004 Phase III trial
Premium
The Fly
Immutep announces first patient dosed in TACTI-004 Phase III trial
5M ago
IMMP
Immutep announces poster presentation for the TACTI-004 Phase III trial
Premium
The Fly
Immutep announces poster presentation for the TACTI-004 Phase III trial
6M ago
MRK
IMMP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >